Dexamethasone phosphate (Medsurge) Inj 4 mg per ml, 2 ml ampoule: Supply issue
The supplier has limited stock of dexamethasone phosphate Inj 4 mg per ml, 2 ml ampoule (Pharmacode: 2690535).
22 April 2026 | Resupply now May 2026
The supplier advises that 2 ml ampoules are now expected to be available again in May 2026. Additional stock of the 1 ml ampoules has arrived in New Zealand to ensure this treatment remains available.
Following a restriction on supply, betamethasone sodium phosphate with betamethasone acetate injections are available again. This may be a suitable alternative for some indications. It is partially funded.
NZF Formulary monograph for betamethasone sodium phosphate with betamethasone acetate(external link)
Affected product
Medsurge (the supplier) has had a manufacturing issue which has delayed the next shipment of this product:
- Chemical: Dexamethasone phosphate
- Presentation: Inj 4 mg per ml, 2 ml ampoule
- Brand: Dexamethasone Medsurge
- Pharmacode: 2690535
- Subsidy: $10.98
- Measure / Qty: per 10
Schedule listing for dexamethasone phosphate(external link)
All other presentations of dexamethasone remain available.
Alternative product
The Inj 4 mg per ml, 1 ml ampoule (Pharmacode: 2690527) is available as an alternative.
Following a restriction on supply, betamethasone sodium phosphate with betamethasone acetate injections are available again. This may be a suitable alternative for some indications. It is partially funded.
NZF Formulary monograph for betamethasone sodium phosphate with betamethasone acetate(external link)
Resupply expected May 2026
Medsurge expects to have supply of the 2 ml ampoule available again in May 2026. Additional stock of the 1 ml ampoule has been sourced to make sure people can continue to access treatment.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)